CCW702 / Scripps Research Institute, AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CCW702 / AbbVie
CBR-CCW702-3001, NCT04077021: First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

Hourglass Jan 2022 - Dec 2022 : Proof-of-concept data from trial for mCRPC
Terminated
1
22
US
CCW702
Calibr, a division of Scripps Research
Metastatic Castration-Resistant Prostate Adenocarcinoma
10/22
10/22

Download Options